Sodium Tetrachloroaurate

OTHER NAME(S): EINECS 239-241-3, Gold Chloride Sodium, Gold Sodium Chloride, Hydrochloroauric Acid (Sodium Salt), Natrium Tetrachloroauratum, Sodium Chloroaurate, Sodium Gold Chloride, Sodium Gold (III) Chloride, Sodium Tetrachloroaurate (1-), Sodium Tetrachloroaurate (3+), Tetrachloroaurate (1-) Sodium, Tetrachloroauric (3+) Acid (Sodium Salt), UNII-7FT6QUT299, Tetracloroaurato Sódico

Overview

Sodium tetrachloroaurate is a gold salt.

Sodium tetrachloroaurate may be used for cancer, but there is no good scientific evidence to support this use.

In December 2019, the U.S. Food and Drug Administration added sodium tetrachloroaurate to the Dietary Supplement Ingredient Advisory List. The ingredients on this list might not be lawful to include in dietary supplements. For this reason, people may want to avoid using supplements containing sodium tetrachloroaurate.

Sodium tetrachloroaurate might reduce inflammation (swelling). It might also kill cancer cells.

Sodium tetrachloroaurate might reduce inflammation (swelling). It might also kill cancer cells.

References
  1. U.S. Food & Drug Administration. Dietary supplement ingredient advisory list. https://www.fda.gov/food/dietary-supplement-products-ingredients/dietary-supplement-ingredient-advisory-list. Accessed December 17, 2019.
  2. Lee MT, Ahmed T, Friedman ME. Inhibition of hydrolytic enzymes by gold compounds. I. beta-Glucuronidase and acid phosphatase by sodium tetrachloroaurate (III) and potassium tetrabromoaurate (III). J Enzyme Inhib. 1989;3(1):23-33.
  3. Suwalsky M, Zambenedetti P, Carpené E, et al. Effects of chronic treatment with sodium tetrachloroaurate(III) in mice and membrane models. J Inorg Biochem. 2004;98(12):2080-6.
  4. Ridaura (auranofin) [package insert]. San Diego, CA: Prometheus Laboratories, Inc; 2011.
  5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Gold Preparations. [Updated 2017 Aug 2].
  6. Eisler R. Chrysotherapy: a synoptic review. Inflamm Res. 2003;52(12):487-501.
  7. Merchant B. Gold, the noble metal and the paradoxes of its toxicology. Biologicals. 1998;26(1):49-59.
  8. Nobili S, Mini E, Landini I, et al. Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. Med Res Rev. 2010;30(3):550-80.
  9. Saito S, Okabe M, Kurasaki M. Localization of renal Cu-binding metallothionein induced by Au injection into rats. Biochim Biophys Acta. 1997;1335(3):353-8.